Skip to main content

Advertisement

Log in

Toxoplasma gondii infection in patients with brain tumors in Southern Iran: a case-control study

  • Original Article
  • Published:
Journal of Parasitic Diseases Aims and scope Submit manuscript

Abstract

Considerable evidence points to a dominant role of inflammation in tumor pathology. The biological response of the immune system can be triggered by Toxoplasma gondii as a common brain-tropic parasite. The aim of this study was to investigate an association between Toxoplasma infection and brain tumors. This case-control study was performed on sera of brain tumor patients (n = 124) and age- and sex-matched control subjects (n = 124) in Southern Iran. Data related to tumor site and type were collected during sample collection. Anti-Toxoplasma IgG was assessed by enzyme-linked immunosorbent assay (ELISA). Seroprevalence anti-Toxoplasma IgG was significantly higher in brain tumor patients 30.6% (38/124) compared with 12.1% (15/124) of the healthy controls (OR 3.211; 95% CI 1.658 to 6.219; p = 0.001). The highest seroprevalence was detected in patients with ependymoma (100%), followed by glioblastoma (83%), pituitary adenoma (47.3%), astrocytoma (27.2%), schwannoma (23%), and meningioma (22.6%). The parasite infection was correlated to brain tumor’s location i.e., the patients with frontal lobe and sella region tumors had higher seropositivity compared with others (P < 0.05). The higher prevalence of Toxoplasma infection among patients with brain tumor compared with the control group indicates a probable association between the infection and brain tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data availability

The data used to support the findings of this study are included within the article.

References

  • Ahmadpour E et al (2014) Toxoplasmosis in immunocompromised patients in Iran: a systematic review and meta-analysis. J Infect Dev Ctries 8(12):1503–1510p

    Article  PubMed  Google Scholar 

  • Arefkha N, Sarkari B, Afrashteh M, Rezaei Z, Dehghani M (2018) Toxoplasma gondii: the prevalence and risk factors in HIV-infected patients in Fars province, southern Iran. Iran Red Crescent Med J 20(6):e66521

    Google Scholar 

  • Arefkhah N et al. (2019) Molecular genotyping and serological evaluation of Toxoplasma gondii in mothers and their spontaneous aborted fetuses in Southwest of Iran. Comp. Immunol. Microbiol. Infect. Dis. 66101342

    Article  PubMed  Google Scholar 

  • Bajelan S, Bahreini MS, Asgari Q, Mikaeili F (2020) Viability and infectivity of Toxoplasma gondii tachyzoites exposed to Butanedione monoxime. J Parasit Dis 44(4):822–828

    Article  PubMed  PubMed Central  Google Scholar 

  • Berenreiterová M, Flegr J, Kuběna AA, Němec P (2011) The distribution of Toxoplasma gondii cysts in the brain of a mouse with latent toxoplasmosis: implications for the behavioral manipulation hypothesis. PLoS ONE 6(12):e28925

    Article  PubMed  PubMed Central  Google Scholar 

  • Bertoli F, Espino M, Arosemena JR, Fishback JL, Frenkel J (1995) A spectrum in the pathology of toxoplasmosis in patients with acquired immunodeficiency syndrome. Arch Pathol Lab Med 119(3):214–224

    CAS  PubMed  Google Scholar 

  • Cabral CM et al (2016) Neurons are the primary target cell for the brain-tropic intracellular parasite Toxoplasma gondii. PLoS Pathog 12(2):e1005447

    Article  PubMed  PubMed Central  Google Scholar 

  • Castro F, Cardoso AP, Gonçalves RM, Serre K, Oliveira MJ (2018) Interferon-gamma at the crossroads of tumor immune surveillance or evasion. Front Immunol 9:847

    Article  PubMed  PubMed Central  Google Scholar 

  • Cheeseman K, Certad G, Weitzman JB (2016) Parasites et cancer: existe-t-il un lien? Med Sci (Paris) 32(10):867–873

    Article  PubMed  Google Scholar 

  • Cong W et al (2015) Toxoplasma gondii infection in cancer patients: prevalence, risk factors, genotypes and association with clinical diagnosis. Cancer Lett 359(2):307–313

    Article  CAS  PubMed  Google Scholar 

  • Correia da Costa JM et al (2014) Schistosome and liver fluke derived catechol-estrogens and helminth associated cancers. Front. Genet 5:444

    Article  PubMed  PubMed Central  Google Scholar 

  • Dai W, Pan H, Kwok O, Dubey J (1994) Human indoleamine 2, 3-dioxygenase inhibits Toxoplasma gondii growth in fibroblast cells. J Interferon Res 14(6):313–317

    Article  CAS  PubMed  Google Scholar 

  • Daryani A et al (2014) Seroprevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis. Acta Trop 137:185–194

    Article  PubMed  Google Scholar 

  • Facer CA, Playfair J (1989) Malaria, Epstein-Barr virus, and the genesis of lymphomas. Adv. Cancer Res 53:33–72

    Article  CAS  PubMed  Google Scholar 

  • Ferlay J et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917

    Article  CAS  PubMed  Google Scholar 

  • Fisch D, Clough B, Frickel E-M (2019) Human immunity to Toxoplasma gondii. PLoS Pathog 15(12):e1008097

    Article  PubMed  PubMed Central  Google Scholar 

  • Jung B-K et al (2016) High Toxoplasma gondii seropositivity among brain tumor patients in Korea. Korean J Parasitol 54(2):201

    Article  PubMed  PubMed Central  Google Scholar 

  • Kalantari N et al (2015) Preliminary study on association between toxoplasmosis and breast cancer in Iran. Asian Pac J Trop Biomed 5(1):44–47

    Article  CAS  Google Scholar 

  • Khabaz MN, Elkhateeb L, Al-Alami J (2011) Reactivation of latent Toxoplasma gondii in immunocompromised cancer patients. Comp Clin Path 20(2):183–186

    Article  CAS  Google Scholar 

  • Kim SK, Boothroyd JC (2005) Stage-specific expression of surface antigens by Toxoplasma gondii as a mechanism to facilitate parasite persistence. J Immunol Res 174(12):8038–8048

    CAS  Google Scholar 

  • Laliberte J, Carruthers VB (2008) Host cell manipulation by the human pathogen Toxoplasma gondii. Cell Mol Life Sci 65(12):1900–1915

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lehrer S (2010) Association between malaria incidence and all cancer mortality in fifty US States and the District of Columbia. Anticancer Res 30(4):1371–1373

    PubMed  Google Scholar 

  • Mendez OA, Koshy AA (2017) Toxoplasma gondii: Entry, association, and physiological influence on the central nervous system. PLoS Pathog 13(7):e1006351

    Article  PubMed  PubMed Central  Google Scholar 

  • Molan AL, Rasheed EH (2016) Study the possible link between toxoplasmosis and different kinds of cancer in Iraq. Am J Life Sci 4:3

    Google Scholar 

  • Mostafa NES et al (2018) The relationship between toxoplasmosis and different types of human tumors. J Infect Dev Ctries 12(02):137–141

    Article  PubMed  Google Scholar 

  • Nourollahpour Shiadeh M et al (2016) The correlation between Toxoplasma gondii infection and prenatal depression in pregnant women. Eur J Clin Microbiol 35(11):1829–1835

    Article  CAS  Google Scholar 

  • Oh JK, Weiderpass E (2014) Infection and cancer: global distribution and burden of diseases. Ann Glob Health 80(5):384–392

    Article  PubMed  Google Scholar 

  • Pang JC, Kwok WK, Chen Z, Ng H-K (2009) Oncogenic role of microRNAs in brain tumors. Acta Neuropathol 117(6):599–611

    Article  CAS  PubMed  Google Scholar 

  • Powell H, Gibbs C, Lorenzo A, Lampert P, Gajdusek D (1978) Toxoplasmosis of the central nervous system in the adult. Electron microscopic observations. Acta Neuropathol 41(3):211–216

    Article  CAS  PubMed  Google Scholar 

  • Remington JS, Cavanaugh EN (1965) Isolation of the encysted form of Toxoplasma gondii from human skeletal muscle and brain. N Engl J Med 273(24):1308–1310

    Article  CAS  PubMed  Google Scholar 

  • Rostami A et al (2020) Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysis.Clin. Microbiol Infect 26(6):673–683

    CAS  Google Scholar 

  • Ryan P et al (1993) Tumours of the brain and presence of antibodies to Toxoplasma gondii. Int J Epidemiol 22(3):412–419

    Article  CAS  PubMed  Google Scholar 

  • Saadat F et al (2020) Seroepidemiology and associated risk factors of Toxoplasma gondii in hemodialysis patients. Acta Parasitol 65(4):906–912

    Article  PubMed  Google Scholar 

  • Sarkari B, Shafiei R, Zare M, Sohrabpour S, Kasraian L (2014) Seroprevalence and molecular diagnosis of Toxoplasma gondii infection among blood donors in southern Iran. J Infect Dev Ctries 8(04):543–547

    Article  PubMed  Google Scholar 

  • Schuman LM, Choi N, Gullen W (1967) Relationship of central nervous system neoplasms to Toxoplasma gondii infection. Am J Public Health 57(5):848–856

    Article  CAS  Google Scholar 

  • Thirugnanam S, Rout N, Gnanasekar M (2013) Possible role of Toxoplasma gondii in brain cancer through modulation of host microRNAsInfect. Agents Cancer 8(1):1–6

    Google Scholar 

  • Thomas F et al (2012) Incidence of adult brain cancers is higher in countries where the protozoan parasite Toxoplasma gondii is common. Biol Lett 8(1):101–103

    Article  PubMed  Google Scholar 

  • Vittecoq M et al (2012) Brain cancer mortality rates increase with Toxoplasma gondii seroprevalence in France. Infect Genet Evol 12(2):496–498

    Article  PubMed  Google Scholar 

  • Yuan Z et al (2007) Toxoplasma gondii antibodies in cancer patients. Cancer Lett 254(1):71–74

    Article  CAS  PubMed  Google Scholar 

  • Zeiner GM, Norman KL, Thomson JM, Hammond SM, Boothroyd JC (2010) Toxoplasma gondii infection specifically increases the levels of key host microRNAs. PLoS ONE 5(1):e8742

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This study was financially supported by the office of vice chancellor for research of Shiraz University of Medical Sciences (Grant no. 95-01-01-12998).

Funding

The authors have not disclosed any funding.

Author information

Authors and Affiliations

Authors

Contributions

QA and NA designed the study; FR and MS B collected the samples; NA, FR carried out the serological method; FS and NA analyzed and interpreted the data. NA drafted the manuscript; FS performed final revision and editing; all the authors read and approved the final version of the manuscript.

Corresponding author

Correspondence to Nasir Arefkhah.

Ethics declarations

Disclosure

This study was the subject of the MD dissertation for Mr. Farshad Rajabi.

Conflict of interest

The authors declare no conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Asgari, Q., Rajabi, F., Sajadian, F. et al. Toxoplasma gondii infection in patients with brain tumors in Southern Iran: a case-control study. J Parasit Dis 47, 291–296 (2023). https://doi.org/10.1007/s12639-022-01541-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12639-022-01541-y

Keywords

Navigation